Kiora Meaningful Vision Improvements in Blind Patients with Retinitis Pigmentosa

 Topline Phase I/II First-in-Human Results Presented at AAO 2023

Significant improvement in visual field, in concordance with trended improvements in visual acuity and functional vision

Functional MRI demonstrates increased brain activity in visual cortex

Novel small molecule photoswitch is safe and tolerable

Company presentation available on IR website (ir.kiorapharma.com)

https://www.biospace.com/article/releases/aao-late-breaking-kiora-s-small-molecule-photoswitch-demonstrates-meaningful-vision-improvements-in-blind-patients-with-retinitis-pigmentosa/